Identifying Maternal Conditions Leading to Gabapentinoid Prescriptions in Pregnancy Using Electronic Health Records from Six European Countries: A Contribution from the IMI ConcePTION Project

Anna‐Belle Beau(Inserm), Christine Damase‐Michel(Université Toulouse III - Paul Sabatier), Aurora Puccini(University of Bologna), Olga Paoletti(Agenzia Regionale di Sanità della Toscana), Laia Barrachina‐Bonet(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Joan K. Morris(St George's, University of London), Clara Cavero‐Carbonell(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Mika Gissler(Finnish Institute for Health and Welfare), Marco Manfrini(University of Padua), Vera Ruth Mitter(Bern University of Applied Sciences), Anja Geldhof, Justine Bénevent(Université Toulouse III - Paul Sabatier), Maarit K. Leinonen(University of Helsinki), Xavier Moisset(Inserm), Rosa Gini(Agenzia Regionale di Sanità della Toscana), Sue Jordan(Swansea University), Elisa Ballardini(University of Ferrara), Visa Martikainen(Finnish Institute for Health and Welfare), Jingping Mo(Pfizer (United States)), Amanda J. Neville(University of Ferrara), Hedvig Nordeng(University of Oslo), Marie Beslay(Université Toulouse III - Paul Sabatier), Alex Coldea(Swansea University), Laura García‐Villodre(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana)

Drug Safety

June 13, 2025

Cited by 1

|New England Journal of Medicine|2013|1k

|The American Journal of Medicine|2009|941

|JAMA Psychiatry|2019|622

|The Lancet Oncology|2017|510

|Transplantation|2002|326

Related Papers